Related Experiment Video
Updated: Aug 19, 2026

Profiling the Triacylglyceride Contents in Bat Integumentary Lipids by Preparative Thin Layer Chromatography and MALDI-TOF Mass Spectrometry
Published on: September 5, 2013
Medium-chain triglycerides inhibit growth of Malassezia: implications for prevention of systemic infection
C Papavassilis1, K K Mach, P A Mayser
1Department of Dermatology and Andrology, Justus Liebig University, Giessen, Germany. charis.papavassilis@derma.med.uni-giessen.de
Objective:
Lipophilic Malassezia species may induce catheter-associated sepsis in newborns and immunocompromised patients receiving parenteral lipids. Therefore, we tested whether M. furfur and six other Malassezia species can use commercially available infusions as a lipid source.
Design:
Prospective in vitro study.
Setting:
Research laboratory in a university hospital.
Interventions:
None.
Measurements And Main Results:
With the exception of M. restricta, all Malassezia species grow on lipid infusions. There are no substantial differences among the different brands. The most rapid growth is shown by M. furfur, which grows better on agar containing a 20% rather than a 10% lipid infusion. Growth of M. furdur and M. sympodialis can be reduced by infusions containing medium-chain triglycerides. Incubated in triglycerides, M. furfur is strongly suppressed by 50% medium-chain triglycerides and M. sympodialis by 8% medium-chain triglycerides. When medium-chain free fatty acids are added to triglycerides, both species can be suppressed by about 1% free fatty acids.
Conclusion:
Medium-chain triglycerides and medium-chain free fatty acids are toxic for Malassezia species. Commercially available infusions containing medium-chain triglycerides might be used to prevent systemic Malassezia infections.
Insights
Certain Malassezia species can grow on lipid infusions, but medium-chain triglycerides and free fatty acids inhibit their growth. These findings suggest using lipid infusions with medium-chain triglycerides to prevent Malassezia infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Lipophilic Malassezia species are associated with catheter-associated sepsis, particularly in neonates and immunocompromised individuals receiving parenteral nutrition.
- Parenteral lipid emulsions are a potential nutrient source for Malassezia species, raising concerns about infection risk.
Purpose of the Study:
- To investigate the ability of various Malassezia species to utilize commercially available lipid infusions as a sole lipid source.
- To evaluate the impact of medium-chain triglycerides (MCTs) and medium-chain free fatty acids (MCFFAs) on Malassezia growth in lipid emulsions.
Main Methods:
- Prospective in vitro study conducted in a university hospital research laboratory.
- Testing of seven Malassezia species, including M. furfur, for growth on different commercially available lipid infusions.
- Assessment of growth inhibition using varying concentrations of MCTs and MCFFAs.
Main Results:
- All tested Malassezia species, except M. restricta, demonstrated growth on lipid infusions, with no significant brand-specific differences.
- M. furfur exhibited the most rapid growth, with enhanced proliferation at 20% lipid concentration compared to 10%.
- Growth of M. furfur and M. sympodialis was significantly reduced by the presence of MCTs, with further suppression by MCFFAs.
Conclusions:
- Medium-chain triglycerides and medium-chain free fatty acids exhibit toxicity towards Malassezia species.
- Commercially available lipid infusions containing MCTs show potential as a preventative strategy against systemic Malassezia infections.
Related Concept Videos
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The Skin Microbiota
The Oral Microbiota
Dysbiosis of the Gut Microbiota
Trichomoniasis
Clinical Significance of Antibiotic Resistance

